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Summary. Campylobacteriosis is a leading cause of bacterial foodborne disease in many industrialized countries including 
Australia. New South Wales (NSW) is the most populous state in Australia yet the lack of any Campylobacter species surveil-
lance programs has led to a knowledge gap in the importance of these pathogens as causes of diarrhoea. The data collected in 
this study demonstrated a need for such programs. In this study, 400 human clinical fecal samples were collected from two 
NSW locations, Western Sydney and Wagga Wagga, and tested for the presence of Campylobacter spp. Patients were clustered 
by location, age and gender to assess Campylobacter spp. prevalence within these groups between the two regions. The 
frequency of Campylobacter spp. was higher in males compared to females in the age groups 0–4 and 5–14 years; 6.4% and 
1.0%, and 8.2% and none, respectively (P < 0.05). A second peak was noted in elderly adults compared with those in younger 
age groups. Based on the findings of the quantitative PCR analysis it was estimated that the age-adjusted prevalence of Campy-
lobacter spp. associated diarrhoea was 159 cases per 100,000 persons. [Int Microbiol 2016; 19(1):33-37]
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Introduction
In Australia, approximately 5.4 million cases of foodborne 
diseases are reported annually resulting in an estimated cost to 
the health system of $1.2 billion per year. Campylobacter spe-
cies have been reported to be the most common enteric patho-
gens amongst all known foodborne pathogens in Australia. 
The annual report produced by “OzFood Net” [21], an Aus-
tralian government initiative which reports on the incidence 
of foodborne diseases, reported 16,968 cases of Campylobac-
ter spp. In 2010. This report, however, excluded the most 
populous state, New South Wales (NSW) [13].
Campylobacteriosis is the leading cause of bacterial food-
borne disease in industrialized countries, including Australia.
The most prevalent species seen in human infection are 
Campylobacter jejuni and C. coli [15]. Human campylobacte-
riosis is generally a self-limiting disease with typical enteric 
symptoms including vomiting, fever, diarrhoea and abdomi-
nal pain [13,25]. Chronic diseases such as reactive arthritis 
and Guillain-Barré syndrome may occur sporadically as a 
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consequence of campylobacteriosis [19]. Campylobacter spp. 
infections are widely prevalent in Australia and infection rates 
have shown a steady increase in recent years [13]. Most 
campylobacteriosis cases in Australia are thought to be spo-
radically acquired [29], showing a similar infection pattern to 
studies conducted in North America [8,23], Europe [10,12] 
and New Zealand [26].
The most important route of Campylobacter infection is 
the consumption and handling of poultry [3]. In fact, in Aus-
tralia, the United States and Europe, 50–70% of all Campylo-
bacter spp. infections have been attributed to the consumption 
of undercooked or contaminated chicken [1,18]. Furthermore, 
improper food handling or inadequate hygiene techniques, as 
well as household pets and domestic chickens are thought to 
be linked to campylobacteriosis in children and adults [28].
However, there has been no direct investigation of the 
wide range of potential human exposure sources or systematic 
exploration of possible ecological cycles of Campylobacter 
spp. in Australia. Human Campylobacter spp. infection is a 
communicable disease in all Australian states and territories, 
apart from NSW, and the data collected can be used to inform 
prevention and control measures. The exclusion of NSW from 
this system means there is no accurate information on either 
the prevalence or incidence of Campylobacter spp. infections 
in this state, which makes the development of more effective 
control polices and measures problematic [13]. 
The aim of this study was to estimate the prevalence of 
Campylobacter spp. in patients with symptoms of diarrhoea 
living in two areas of NSW who sort medical care. Prevalence 
of Campylobacter spp. in different study population catego-
ries were also compared to determine if factors such as patient 
age or gender influenced the Campylobacter spp. infection 
prevalence.
Materials and methods
Study design and locations. A cross-sectional study was conducted 
to investigate the prevalence of Campylobacter spp. infection at the Microbi-
ology Department of the Westmead Hospital in Western Sydney and the Mi-
crobiology Department of the Wagga Wagga Base Hospital from October 
2012 to February 2014. A total of 400 (n = 200 Wagga Wagga, n = 200 West-
ern Sydney) diarrhoeal samples, as defined according to World Health Or-
ganization guidelines, were opportunistically collected from the faecal sam-
ples submitted for routine analysis and culture at these two laboratories for 
the duration of the sampling period. The Australian Bureau of Statistics has 
described Sydney and Wagga Wagga as a major city and an inner regional 
city respectively.
Sample collection. Clinical faecal samples were aliquoted in sterile 
containers and an appropriate code was assigned to each sample. The samples 
were refrigerated after routine testing was completed by the Microbiology 
Departments at both locations. Samples from western Sydney were placed on 
ice and transported to Charles Sturt University for DNA extraction within 24 
h of collection. Samples collected at the Wagga Wagga Base Hospital were 
transported to the university laboratory within one hour and processed im-
mediately.
DNA extraction. Total DNA was extracted from human faecal samples 
using QIAamp DNA Stool Mini Kit (QIAGEN Pty Ltd, Australia). An aliquot 
of the sample (200 µl) was transferred to a 2-ml Eppendorf tube and heated 
to 70 oC for 10 min. Total DNA was extracted using the manufacturer’s pro-
tocol. The final elution volume of DNA was 200µL. The DNA samples were 
stored at –20 oC prior to PCR analysis. 
Real time PCR assay (qPCR). The presence or absence of DNA from 
Campylobacter spp. in the clinical sample extracts was determined by using 
quantitative real-time PCR (qPCR). The qPCR primers and the probe used 
were modified from previously published studies [4,6]. The qPCR assay was 
designed to detect all Campylobacter spp. by targeting the 16S rRNA gene 
using the primer pair Lund_16S_F 5´-CGT GCT ACA ATG GCA TAT ACA 
ATG A-3´ and Lund_16S_R 5´-CGA TTC CGG CTT CAT GCT C-3´. A 
novel 16S probe, Campy_16S-LNACy5 Campylobacter Cy5-5´-ATA [+G] 
AT [+T] TC [+C] AC C-3´-BHQ3 (Sigma-Aldrich, Australia) was designed 
using Beacon Designer version 8.12 (Premier Biosoft International). The nu-
cleotide residues designated as [+N] have been modified with locked nucleic 
acid technology [5,14]. Briefly, the LNA probe was designed by importing 
the forward and reverse oligonucleotides into the software, and the default 
settings used to identify the optimal probe sequence within the 44bp ampli-
con. To confirm that the optimal probe sequence was identical to Campylo-
bacter spp. 16S sequences and to assess the likelihood of cross-reaction with 
bacterial species that might be present in clinical samples, a Primer-BLAST 
search was performed [30]. 
All qPCR assay runs included control templates from strains; C. jejuni 
NCTC 11168, C. jejuni ATCC 29428, C. jejuni ATCC 49943, C. coli NCTC 
11366, and C. coli ATCC 33559. Each qPCR reaction volume of 20 µl con-
tained 10 µl of 2 × TaqMan master mix (Applied Biosystems), 16S forward 
primer 0.2 µM, 16S reverse primer 0.2 µM, 16S probe 0.2 µM. DNA tem-
plate 1 µl was used with the following conditions; Taq Hot Start for 15 min at 
95 oC, one cycle, 40 cycles of denaturation for 1 min at 95 oC, annealing and 
extension for 1 min at 60 oC in the Rotor-Gene Q (QIAGEN).
Data analysis. The qPCR results were analyzed using Rotor-Gene Q Se-
ries software. The cycle threshold values determined based on the run param-
eters with software default setting. Population denominators were obtained 
for the relevant NSW regions from the Australian Bureau of Statistics data, 
with 2011 being the most recent data collection year. The Western Sydney 
population for the year 2011 was 846,001 and for Wagga Wagga was 237,338. 
For the estimation of prevalence per 100,000, the NSW 2011 standard popu-
lation data of 7,218,529 was used [20,22]. Based on the age distribution of 
cases used in previous studies [7,9], the following age groups were identified 
for data analysis and age–specific prevalence of Campylobacter spp.: 0–4, 
5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74 and ≥75 years were calcu-
lated. Samples from all age groups were included in this study. Samples from 
both genders were also included in the study.
The sample results were tabulated using the package software Statistical 
Package for the Social Sciences (SPSS, version 20). An unconditional logis-
tic regression model was used in multivariate analysis. Chi-square analysis 
was performed to compare results in various groups with P < 0.05, deemed to 
be statistically significant.
Ethics approval. This study was approved by the Charles Sturt Univer-
sity Ethics in Human Research Committee, with approval for sample collec-
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tion also granted by the Pathology Department managers at each of the hos-
pital sites used in this study. The approvals permitted the collection of basic 
patient information on age and gender, in a de-identified manner to protect 
patient confidentiality.
Results and Discussion
Prevalence of infection. This study reports a Campylo-
bacter spp. population adjusted prevalence of Campylobacter 
spp of 159 cases per 100,000 population in NSW (Fig. 1). The 
estimate was determined by testing, in diarrhoea samples (n = 
400) collected from the two locations, the presence of Campy-
lobacter spp DNA by qPCR. Campylobacter spp. were detect-
ed in 209 of the samples tested, giving a Campylobacter spp. 
prevalence of 52.3% (95%; confidence interval 47.8–58.3%) 
(Table 1). The NSW prevalence estimate was higher than the 
Australian case rate of 93.5 cases per 100,000 population, with-
out including NSW data during 2013 when the majority of the 
study samples were collected [2]. Regarding the various Aus-
tralian states, the data collected in this study suggested that 
NSW and Tasmania the most similar rates of human Campylo-
bacter spp. infections, with 158.9 and 135.7 cases per 100,000 
population respectively for 2013 (Fig. 1). Somewhat surpris-
ingly, the Australian Capital Territory, located within NSW, had 
a much lower case rate of 98.4 cases per 100,000 for this year 
compared to the jurisdictions (Fig. 1) [2]. Differences in popu-
lation size, demographics and health polices within each juris-
diction suggest that additional research is required to establish 
if risk factors for infection are also similar. 
The higher prevalence of Campylobacter spp. in NSW re-
ported in this study compared to other states may have resulted 
from the detection methodologies used. Culture is often consid-
ered the gold standard technique for Campylobacter spp. and it 
is used in most microbiology laboratories across Australia, 
while the current study has used qPCR to determine the results 
for NSW. It is well established in the literature that qPCR is 
more sensitive than culture for the detection of fastidious 
[16,17,24]. Due to the fastidious and liable nature of Campylo-
bacter spp., culture-based detection might underestimate the 
true prevalence in a population. In contrast, qPCR would be 
more likely to overestimate the true prevalence of Campylobac-
ter spp. as it could detect both live and dead bacteria in the 
samples. This study utilised qPCR as the detection method to 
ensure that the results from samples collected at different loca-
tions were comparable. In fact, samples from Western Sydney 
could not be tested for at least 24 h after collection while those 
from Wagga Wagga could be processed just one hour after hav-
ing been collected. Therefore, the use of culture could have dra-
matically underestimated the true prevalence in Western Syd-
ney. Moreover, the estimated prevalence for NSW in this study 
is consistent with, albeit higher, analogous data from other Aus-
tralian states determined using culture (Fig. 1), which suggests 
that qPCR detection is a rapid, sensitive and cost-effective 
method of detecting this pathogen.
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Fig. 1. Comparative prevalence of Campylobacter 
species infection per 100,000 population in NSW (this 
study) and other Australian states and territories in 
2013; Australian Capital Territory (ACT), New South 
Wales (NSW), Northern Territory (NT), Queensland, 
(Qld), South Australia (SA), Tasmania (Tas), Victoria, 
(Vic), and Western Australia (WA). The 2011 popu-
la tion census NSW HealthStats from the Australia 
Bureau of Statistics were used to calculate rate per 
100,000 population.
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Distribution of infection by age. The distributions 
of Campylobacter spp. positive samples by age and gender 
are shown in Table 1. The highest prevalence of Campylobac-
ter spp. infections were found in age groups 55–64, 65–74 
and ≥75 years (16.7%, 19.6% and 23.9%) respectively. The 
lowest numbers of cases were in children and youngsters 
aged 0–4, 5–14 and 25–34 (3.8%, 4.3% and 4.8% respective-
ly (Table 1). Age details were not available for six samples 
two of which were positive for Campylobacter spp. and as a 
result these could not be included in the analysis. A previous 
cohort study reported a higher prevalence for the 0–4year-old 
group [11]. In comparison the current study included samples 
from all age groups as it was reliant on the opportunistic sam-
pling of the study population. Another reason for the lower 
prevalence and reduced number of samples in the 0–4-year-
old group of the current study could be the limited pediatric 
services provided at the Westmead hospital where the sam-
pling was conducted; therefore, patients in this age group 
might have been treated in another hospital such as Childrens’ 
hospital for specialised treatment.
Prevalence of infection by gender. When compar-
ing males and females, no significant differences in the 
Campylobacter spp. prevalence were found, although the 
frequency was slightly higher for males (52.6%) than for 
females (47.4%) (Table 1). In the age groups 0–4 and 
5–14 years, statistically significant differences were noted 
in the number of Campylobacter spp. infection in males 
(6.4%) compared with females (1.0%), and 8.2% in males 
and none in females, respectively (P < 0.05). In the 35–44 
age range, significantly higher prevalences of Campylo-
bacter spp. were detected in females with 11.1% compared 
to 4.5% in males (P < 0.05, Table 1). For the age groups 
25–34 and ≥75, the prelences were higher in females than 
in males (P < 0.05, Table 1). The gender differences in 
Campylobacter spp. prevalence identified in the present 
study were largely in agreement with rates reported in an-
other similar study [27]. 
We can conclude that this study provides significant data 
on selected demographic determinants, as well as trends of 
Campylobacter spp. infections in NSW, Australia. The data 
collected in this study suggest that NSW might have the high-
est prevalence of Campylobacter spp. infections among all of 
the Australian health jurisdictions. To obtain more detailed 
data on the prevalences of Campylobacter spp. infections in 
the whole country, mandatory reporting in NSW would be 
highly desirable as this would effectively establish a national 
surveillance program. The results reported in this study sug-
gest that more research into the role of Campylobacter spp. in 
the cases of diarrhoea could help to determine the effects of a 
wide range of risk factors in NSW and all Australia and under-
pin better control measures. 
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Table 1. Categorisation of Campylobacter spp. positive diarrhoeal specimens by age and gender determined using 
quantitative real time PCR (n = 394*)
Patient sex
All Samples Male Female
Age group (years) Tested Positive (%) Positive (%) Positive (%)
0-4 12 8 (3.8) 7 (6.4) 1 (1.0)
5-14 15 9 (4.3) 9 (8.2) 0
15-24 24 10 (4.8) 6 (5.5) 4 (4.0)
25-34 34 20 (9.5) 9 (8.2) 11 (11.1)
35-44 23 16 (7.7) 5 (4.5) 11 (11.1)
45-54 40 20 (9.6) 9 (8.2) 11 (11.1)
55-64 58 35 (16.7) 21 (19.0) 14 (14.1)
65-74 76 41 (19.6) 21 (19.0) 20 (20.2)
>75 112 50 (23.9) 23 (20.9) 27 (27.3)
Total 394* 209 110 99
* Information on patient age and gender for six samples, of which two were positive from Wagga Wagga, were missing 
and therefore not included in this table.
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